Navigation Links
Cypak Compliancy Connection Powers Stora Enso Pharma DDSi
Date:11/20/2007

STOCKHOLM, November 20 /PRNewswire/ -- Stora Enso, a leading producer of pharmaceutical packaging boards, has launched Pharma DDSi , the first intelligent pharmaceutical packaging solution to use Cypak's Compliancy Connection.

Compliancy Connection is a standard low-cost electronic module built around a single RFID microchip and is designed to be embedded in pharmaceutical packaging. Electronic sensors are printed onto the packaging to detect when a dose of medicine is removed.

Non-compliance is increasingly recognized as a major problem in health care. Experts believe that over 50% of people do not take their medication as prescribed, causing tens of thousands of avoidable admissions to hospitals and care homes.

There are many reasons for non-compliancy. Memory lapses result in people skipping a dose or even taking multiple doses. Some people worry about side-effects, others misinterpret the instructions on how to take the medication. Sometimes children take medicines that are not intended for them, and older people struggle to open the packaging. Lack of objective compliancy data may even cause doctors to switch medication or increase dosage levels unnecessarily.

Pharma DDSi is a holistic solution that improves compliancy, providing objective data to caregivers and patients alike:

- Electronics embedded in the package provide reminders, record medication events, and transmit the medication history to the care-giver.

- A printed questionnaire captures the patient's feelings when taking medication. Direct communication to a specialist warns of side-effects and enables early intervention.

- DDSi is a carton solution. Clear instructions for use are printed on the packaging.

- Stora Enso also offers child resistant and senior friendly packaging solutions.

Pharma DDSi works with a variety of database solutions including PackAgent Compliance Monitoring software. This system is used for tracking and tracing the packages, capturing the compliance data and sharing results.

Per Nathanaelson, Cypak CEO, comments: "The low-cost electronic solution provided by Cypak, combined with Stora Enso's expertise, is further opening the way for widespread global adoption of intelligent pharmaceutical packaging."

Ismo Saarinen, Director, Pharmaceutical Solutions, Stora Enso, comments: "Pharma DDSi is a ground breaking solution. Together with Cypak we will continue to drive innovation, affordability, and connectivity."

Links: http://www.cypak.com and http://www.storaenso.com/pharma


'/>"/>
SOURCE Cypak AB
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
3. Vitasoy Promotes the Soy Breast Health Connection
4. Randy Jackson and the American Heart Association Promote Awareness about the Connection Between Type 2 Diabetes and Cardiovascular Disease
5. Research examines connection between substance abuse and violence
6. Bestselling Author Dr. Timothy Brantley Explains the Connection of Food and Mood
7. Study finds no connection between vitamin D and overall cancer deaths
8. Free Seminar Features State Funds Back Connection(TM), November 14, in Chico
9. Free Seminar Presents State Funds Back Connection(TM), November 13, in Redding
10. Hormonal Changes and Depression: What is the Connection?
11. Health Knowledge Empowers the Public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... , ... April 21, 2017 , ... ... it’s been named Agency of Record (AOR) for Theravent, Inc. , the ... snoring. Theravent’s parent company, Foundation Consumer Healthcare, is now working to expand distribution ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover ... O2X , an active lifestyle company that provides Human Performance Training and ... firefighters, police offers, first responders, military officers and others in service through the ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Alive for ... who wish to overcome their mental health struggles. The Alive team uses advanced ... says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... ... 21, 2017 , ... Northern California Medical Associates ... Symposium on April 1, 2017 in Santa Rosa. This well-attended annual conference plays ... an opportunity to learn about cutting edge treatments, to collaborate, share research and ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... practices, is seeking candidates to serve on its Accreditation and Standards Committees ... “RadSite’s ultimate mission is improving image quality and reducing patient radiation dose,” ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
Breaking Medicine Technology: